IPO registrations (S-1, F-1) · Registrants

Nexalin Technology, Inc.

SEC CIK
1527352 · filings on EDGAR ↗
Registration
Form S-1, first filed 2022-01-04, last 2026-10-08; 4 initial registrations, 15 amendments
Outcome
Final prospectus filed 2022-09-19; declared effective 2022-09-15; withdrawal requested 2024-05-14
Industry (SIC)
Electromedical & Electrotherapeutic Apparatus 3845
Incorporated in
DE
Business address
1776 YORKTOWN, SUITE 550, Houston, TX 77056
EIN
27-5566468
Ticker
NXL (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Nexalin Technology, Inc. on the corporate pages

Offering terms

Proposed price range
$6.00–$7.00 per share (S-1/A filed 2022-09-15)
Final price
$4.15 per share, below the range (424B4 filed 2022-09-19, an initial public offering)
Shares sold
2,315,000
Gross proceeds
$9,607,250 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol NXL
Lead underwriters
Maxim Group

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 29

FiledFormWhat it isName as filedEDGAR
2022-01-04S-1S-1 (registration)Nexalin Technology, Inc.0001174947-22-000015 ↗
2022-01-31S-1/AS-1/A (amendment)Nexalin Technology, Inc.0000891092-22-000235 ↗
2022-02-04S-1/AS-1/A (amendment)Nexalin Technology, Inc.0000891092-22-000351 ↗
2022-04-08S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-22-007966 ↗
2022-04-28S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-22-008910 ↗
2022-05-16S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-22-011103 ↗
2022-05-31S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-22-012325 ↗
2022-08-24S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-22-016146 ↗
2022-09-15S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-22-016882 ↗
2022-09-15S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-22-016885 ↗
2022-09-15EFFECTEFFECT (declared effective)Nexalin Technology, Inc.9999999995-22-002714 ↗
2022-09-19424B4424B4 (final prospectus)Nexalin Technology, Inc.0001829126-22-016957 ↗
2024-05-14RWRW (withdrawal request)Nexalin Technology, Inc.0001829126-24-003342 ↗
2024-05-23S-1S-1 (registration)Nexalin Technology, Inc.0001829126-24-003705 ↗
2024-06-14S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-24-004207 ↗
2024-06-24S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-24-004393 ↗
2024-06-26S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-24-004428 ↗
2024-06-27EFFECTEFFECT (declared effective)Nexalin Technology, Inc.9999999995-24-001990 ↗
2024-07-01424B4424B4 (final prospectus)Nexalin Technology, Inc.0001829126-24-004494 ↗
2024-12-20S-1S-1 (registration)Nexalin Technology, Inc.0001829126-24-008446 ↗
2025-01-10S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-25-000158 ↗
2025-01-30S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-25-000571 ↗
2025-02-03EFFECTEFFECT (declared effective)Nexalin Technology, Inc.9999999995-25-000284 ↗
2025-04-29EFFECTEFFECT (declared effective)Nexalin Technology, Inc.9999999995-25-001291 ↗
2025-05-02424B4424B4 (final prospectus)Nexalin Technology, Inc.0001829126-25-003319 ↗
2025-05-06424B4424B4 (final prospectus)Nexalin Technology, Inc.0001829126-25-003425 ↗
2026-09-03S-1S-1 (registration)Nexalin Technology, Inc.0001829126-26-009723 ↗
2026-10-08S-1/AS-1/A (amendment)Nexalin Technology, Inc.0001829126-26-010913 ↗
2026-10-15EFFECTEFFECT (declared effective)Nexalin Technology, Inc.9999999995-26-003253 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2022-09-15S-1/Aregistration statement$6.00–$7.00$6.001,500,000$9,000,000Nasdaq NXL1primary document; range, price sentence, shares headline, proceeds tabledocument ↗
2022-09-19424B4final prospectus$4.152,315,000$9,607,250Nasdaq NXL1primary document; price sentence, shares headline, proceeds tabledocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Elson MarilynOfficer,TenPercentOwner; Other; TenPercentOwnerMs. Elson serves as CFO102022–2025
Hu BenDirector52022–2025
Kazden AlanDirector72022–2025
Morad RickDirector42022–2023
OSSER LEONARDOther; TenPercentOwner; TenPercentOwner,Other102022–2025
Owens DavidDirector,OfficerChief Medical Officer172022–2025
White MarkDirector,OfficerCEO; President and CEO; President/CEO72022–2025
Bernhard LeslieDirector12024
Shelton Carolyn HambyOfficerSenior VP; Sr. VP - Quality - Regulatory; Sr. VP - Quality, Regulatory42025
Van Fleet JustinOfficerCFO22025

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationNEXALIN TECHNOLOGY, INC.TXState business registriesname and state
Lobbying clientNEXALIN TECHNOLOGY INC.TXFederal lobbying (LDA)name and state
Patent assigneeNEXALIN TECHNOLOGY, INC.TXPatents (USPTO)name and state
SEC filerNexalin Technology, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerNEXALIN TECHNOLOGY, INC.TXTrademarks (USPTO)name and state

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Electromedical & Electrotherapeutic Apparatus, TX first:

More with this interest.

In other datasets, the same topic (Technology) in TX:

Interests: Electromedical & Electrotherapeutic Apparatus · Technology